Hunan ER-KANG Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hunan ER-KANG Pharmaceutical Co Ltd with three other
companies in this sector in China:
Shandong Lukang Pharmaceutical
sales of 2.51 billion Chinese Renmimbi [US$363.61 million]
of which 67%
was Human Antibiotic),
ChangChun High New Technology Industries
(2.87 billion Chinese Renmimbi [US$417.11 million]
of which 81%
was Medication), and
Shanxi Zhendong Pharmaceutical Co Ltd
(3.28 billion Chinese Renmimbi [US$476.36 million]
of which 94%
was Medicine Manufacture and Sale).
Hunan ER-KANG Pharmaceutical Co Ltd reported sales of 2.96 billion Chinese Renmimbi (US$429.74 million)
December of 2016.
increase of 68.6%
versus 2015, when the company's sales were 1.76 billion Chinese Renmimbi.
Sales at Hunan ER-KANG Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 387%).